Pfizer

Washington: An expert committee convened by the US Food and Drug Administration (FDA) has voted heavily in favour of recommending the Pfizer-BioNTech COVID-19 vaccine for emergency use…

New York: Pfizer has decided to keep a differential pricing on its COVID-19 vaccine, which will be based on a country's GDP. CEO Albert Bourla has said the vaccine will have tiered…

New York: The US Food and Drug Administration (FDA) has revealed that the COVID-19 vaccine developed by Pfizer-BioNTech saw four volunteers developing temporary facial paralysis or Bell's…

London: Regulators have added allergic reaction warnings for Pfizer's COVID-19 vaccine. Anyone with a history of significant allergic reactions are advised not to have the vaccine shot.…

London:  Dr Hari Shukla, 87 and his wife Ranjan, 83-year-old wife from the northeast of England on Tuesday became the first Indian-origin couple in the world to get a vaccine against…

Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from the Drug Controller General of India (DCGI). Now,…

New Delhi: The Serum Institute of India (SII) has sought emergency use authorisation of its vaccine candidate Covishield in the country. The Pune-based SII is conducting the India trials…

London: The frontrunners in the race to develop a coronavirus vaccine continue to show positive results. After Pfizer and Moderna reported extremely encouraging data from final-stage…

New York: Pfizer Inc PFE.N and BioNTech 22UAy.DE could get emergency US and European approval for their COVID-19 vaccine in December after final trial results showed a resounding 95 per cent…

London: Pharma major Pfizer on Wednesday reported that its COVID-19 vaccine is 95 per cent effective in phase 3 trials and would be applying for emergency US authorization within days.…